Alexander Lawandi

1.2k total citations · 1 hit paper
33 papers, 503 citations indexed

About

Alexander Lawandi is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Alexander Lawandi has authored 33 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 9 papers in Infectious Diseases and 9 papers in Pharmacology. Recurrent topics in Alexander Lawandi's work include Antibiotic Use and Resistance (9 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Alexander Lawandi is often cited by papers focused on Antibiotic Use and Resistance (9 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Alexander Lawandi collaborates with scholars based in Canada, United States and Singapore. Alexander Lawandi's co-authors include Todd C. Lee, Guillaume Butler‐Laporte, Emily G. McDonald, Ian Schiller, Mandy Yao, Nandini Dendukuri, Matthew P. Cheng, Katryn Paquette, Cédric P. Yansouni and Chelsea Caya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Alexander Lawandi

29 papers receiving 497 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2

2021 192 citations Guillaume Butler‐Laporte, Alexander Lawandi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Lawandi Canada	9	270	188	110	78	62	33	503
Katryn Paquette Canada	12	186 0.7×	187 1.0×	95 0.9×	30 0.4×	32 0.5×	19	577
Philipp Jent Switzerland	10	135 0.5×	117 0.6×	22 0.2×	42 0.5×	41 0.7×	26	364
Noah Wald‐Dickler United States	11	237 0.9×	174 0.9×	62 0.6×	15 0.2×	47 0.8×	20	466
Valentijn A. Schweitzer Netherlands	8	124 0.5×	123 0.7×	38 0.3×	35 0.4×	98 1.6×	26	353
Geert H. Groeneveld Netherlands	13	124 0.5×	347 1.8×	65 0.6×	10 0.1×	28 0.5×	30	566
Eleonora Zamparini Italy	13	410 1.5×	145 0.8×	155 1.4×	18 0.2×	44 0.7×	31	731
Anna Chiu United States	11	261 1.0×	155 0.8×	156 1.4×	7 0.1×	74 1.2×	15	542
G Smith United Kingdom	9	123 0.5×	99 0.5×	47 0.4×	13 0.2×	26 0.4×	12	401
Frank Haamann Germany	7	160 0.6×	60 0.3×	62 0.6×	25 0.3×	15 0.2×	10	360
Diana L. Pakstis United States	14	360 1.3×	476 2.5×	28 0.3×	36 0.5×	36 0.6×	19	994

Countries citing papers authored by Alexander Lawandi

Since Specialization

Citations

This map shows the geographic impact of Alexander Lawandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Lawandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Lawandi more than expected).

Fields of papers citing papers by Alexander Lawandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Lawandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Lawandi. The network helps show where Alexander Lawandi may publish in the future.

Co-authorship network of co-authors of Alexander Lawandi

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Lawandi. A scholar is included among the top collaborators of Alexander Lawandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Lawandi. Alexander Lawandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Todd C., Alexander Lawandi, Connor Prosty, et al.. (2025). Systemic Corticosteroids Continue to Reduce Mortality in Severe Community-Acquired Pneumonia: An Updated Meta-Analysis. PubMed. 41(1). 239–241.

Lawandi, Alexander, Chelsea Caya, Todd C. Lee, et al.. (2025). Antibiotic synergy against Staphylococcus aureus : a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy. 69(8). e0119924–e0119924.

Sohani, Zahra, Makeda Semret, Matthew P. Cheng, et al.. (2025). Comparison of ciprofloxacin and aminoglycoside susceptibility testing for ceftriaxone non-susceptible Enterobacterales by disk diffusion and VITEK 2 vs. broth microdilution using updated Clinical and Laboratory Standards Institute breakpoints. BMC Microbiology. 25(1). 175–175. 1 indexed citations

Strich, Jeffrey R., Guoqing Diao, Alexander Lawandi, et al.. (2024). Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals. Annals of Internal Medicine. 177(5). 559–572. 9 indexed citations

Prosty, Connor, Jesse Papenburg, Alexander Lawandi, et al.. (2024). Causal role of the gut microbiome in certain human diseases: a narrative review. SHILAP Revista de lepidopterología. 2(3). e100086–e100086. 5 indexed citations

Babiker, Ahmed, Sarah Warner, Xiaobai Li, et al.. (2024). Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation. The Lancet Infectious Diseases. 25(3). 265–275. 6 indexed citations

Kam, Kai‐Qian, Tom Chen, Sameer S. Kadri, et al.. (2024). Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals. Clinical Infectious Diseases. 80(1). 108–117. 4 indexed citations

Sohani, Zahra, Mical Paul, Dafna Yahav, et al.. (2024). Establishing piperacillin–tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurements vs. broth microdilution. Clinical Microbiology and Infection. 31(4). 575–581.

Rhee, Chanu, Tom Chen, Sameer S. Kadri, et al.. (2024). Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US Hospitals. JAMA Network Open. 7(6). e2418923–e2418923. 19 indexed citations

10.

Lawandi, Alexander, Sameer S. Kadri, & John H. Powers. (2023). Focusing on antimicrobial resistant infections –are we missing the forest for the trees and the patients for pathogens?. SHILAP Revista de lepidopterología. 2. 1329081–1329081. 1 indexed citations

11.

Corpo, Olivier Del, Julien Senécal, Jimmy Ming-Yang Hsu, Alexander Lawandi, & Todd C. Lee. (2023). Rapid phenotypic testing for detection of carbapenemase- or extended-spectrum ß-lactamase-producing Enterobacterales directly from blood cultures: a systematic review and meta-analysis. Clinical Microbiology and Infection. 29(12). 1516–1527. 8 indexed citations

12.

Strich, Jeffrey R., Alexander Lawandi, Sarah Warner, et al.. (2023). Association between piperacillin/tazobactam MIC and survival among hospitalized patients with Enterobacterales infections: retrospective cohort analysis of electronic health records from 161 US hospitals. JAC-Antimicrobial Resistance. 5(2). dlad041–dlad041. 5 indexed citations

13.

Yek, Christina, Alexander Lawandi, Scott Evans, & Sameer S. Kadri. (2023). Which trial do we need? Optimal antibiotic duration for patients with sepsis. Clinical Microbiology and Infection. 29(10). 1232–1236. 1 indexed citations

14.

Lawandi, Alexander, Sarah Warner, Guoqing Diao, et al.. (2023). Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum: Real-World Utilization and Performance Characteristics, 65 U.S. Hospitals, 2008–2017*. Critical Care Medicine. 51(11). 1527–1537. 3 indexed citations

15.

Cheng, Matthew P., et al.. (2020). Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial. Clinical Infectious Diseases. 72(9). e196–e203. 40 indexed citations

16.

Lee, Todd C., Marnie Goodwin Wilson, Alexander Lawandi, & Emily G. McDonald. (2020). Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis. The American Journal of Medicine. 134(3). e184–e188. 8 indexed citations

17.

Cheng, Matthew P., Robert Stenstrom, Katryn Paquette, et al.. (2019). Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis. Annals of Internal Medicine. 1 indexed citations

18.

Lawandi, Alexander, Matthew P. Cheng, & Todd C. Lee. (2019). Hepatitis B testing practices at a tertiary care centre and their associated costs: A retrospective analysis. PLoS ONE. 14(7). e0219347–e0219347. 2 indexed citations

19.

Lawandi, Alexander, Cédric P. Yansouni, Michael Libman, et al.. (2018). A 9-Year-Old Female With a Cough and Cavitary Lung Lesion. Clinical Infectious Diseases. 69(4). 705–708. 2 indexed citations

20.

Cheng, Matthew P., Alexander Lawandi, Guillaume Butler‐Laporte, Katryn Paquette, & Todd C. Lee. (2018). Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial. Trials. 19(1). 297–297. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact